Concentrix
CNXC
325 hedge funds and large institutions have $4.93B invested in Concentrix in 2023 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 104 increasing their positions, 110 reducing their positions, and 37 closing their positions.
16% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 37
1% more funds holding
Funds holding: 323 → 325 (+2)
0.33% more ownership
Funds ownership: 77.58% → 77.91% (+0.33%)
4% less capital invested
Capital invested by funds: $5.13B → $4.93B (-$195M)
5% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 110
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less call options, than puts
Call options by funds: $17.4M | Put options by funds: $25.5M
Top Buyers
Top Sellers
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$84.7M |
| 2 |
ABI
Abrams Bison Investments
Bethesda,
Maryland
|
-$48.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$27.7M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$21.3M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$21.2M |
CNXC Hedge Fund Activity: Q1 2023 in Review
325 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Concentrix (CNXC) for Q1 2023, worth a combined $4.93B — down 3.8% from $5.13B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CNXC positions and 37 closed out — a net gain of 6 holders — while 104 added to existing stakes and 110 trimmed.
The largest buyer was Impactive Capital, adding an estimated $180M. The largest seller was Boston Partners, cutting an estimated $84.7M.
- 325 institutional investors held Concentrix (CNXC) as of Q1 2023, up from 323 in Q4 2022.
- Funds reported $4.93B of Concentrix stock for Q1 2023, down 3.8% quarter-over-quarter.
- 43 funds opened new Concentrix positions in Q1 2023 and 37 closed out, a net change of +6 holders.
- The largest Concentrix buyer in Q1 2023 was Impactive Capital, an estimated $180M added.
- The largest Concentrix seller in Q1 2023 was Boston Partners, an estimated $84.7M sold.
Based on aggregated 13F filings for Q1 2023.